Material and Methods

TSC2
+/+ MEFs, TSC2 -/-MEFs, MCF10A expressing pBabe-empty vector or PI3KCA H1047R , HeLa cells, U87MG cell line were used in this study. To determine the relative levels of intracellular metabolites, extracts were prepared and analyzed by LC/MS/MS [3] . Regarding the U-14 C-aspartate, U-14C-glycine incorporation into RNA and DNA, cells were serum starved for 15 hours and treated as indicated. Cells were harvested and RNA or DNA was isolated using Allprep DNA/RNA kits according to the manufacturer's instructions and quantified using a spectrophotometer. For statistical analysis a two-tailed Student's t-test was performed for all pairwise comparisons (n=3).
Results
We find that activation of mTORC1 leads to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway [4] . We recently found that mTORC1 stimulates the de novo purine synthesis pathway. In contrast with pyrimidine synthesis, the regulation of the purine synthesis by mTORC1 signaling occurs through long-term mechanism. Indeed, we found that mTORC1 regulates the de novo purine synthesis pathway through the transcription factor SREBP.
Conclusion
These findings demonstrate that growth signaling through mTORC1 promotes the production of new nucleotides to facilitate an increased demand for RNA and DNA. mTOR appears to be a central regulator of de novo nucleotide synthesis. Therefore, nucleotide synthesis joins protein and lipid synthesis as major anabolic processes stimulated by mTORC1 signaling. 
